Cristhian Vallejo Burgos

Dr. Cristhian Vallejo Burgos

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CDCarmelo Dueñas-Castell
Carmelo Dueñas-Castell
Jose Alfredo Correa GuerreroJose Alfredo Correa Guerrero
Jose Alfredo Correa Guerrero
DBDayro Enrique Rodelo barrios
Dayro Enrique Rodelo barrios
LVLuis Valderrama-Ortiz
Luis Valderrama-Ortiz
CBCristhian Vallejo Burgos
Cristhian Vallejo Burgos
EOElber Luis Osorio-Rodriguez
Elber Luis Osorio-Rodriguez
Acute respiratory failure (ARF) often leads to ICU admission, ventilatory support, illness, and death. The usual classification into hypoxemic and hypercapnic types does not capture its full complexity. Precision medicine uses the concept of “treatable traits” to guide care based on traits that are clinically relevant, identifiable, measurable, and possibly changeable. Arterial carbon dioxide pressure (PaCO2) reflects factors like alveolar ventilation, dead space, respiratory mechanics, and how patients respond to ventilatory support. This makes it clinically relevant in selected situations. We carried out a scoping review using PRISMA-ScR and JBI guidelines to summarize evidence on hypocapnia and hypercapnia as prognostic, stratification, or clinically relevant variables during respiratory support. We searched PubMed/MEDLINE, ScienceDirect, and Web of Science (1994–2025), and checked references by hand. Thirty-four studies met our criteria and were grouped into four areas: pre-intubation or early acute presentation, non-invasive support (NIV/HFNC), invasive mechanical ventilation (IMV), and weaning or post-extubation. In summary, hypocapnia was linked to worse outcomes or failure of support in hypoxemic or cardiogenic cases. Hypercapnia helped identify patients who benefited from NIV, such as those with chronic obstructive pulmonary disease or obesity hypoventilation. For IMV, the effects depended on the presence and severity of acidosis and on its duration. Overall, PaCO2 showed context-dependent clinical relevance, acting mainly as a prognostic or stratification marker and, in narrower settings, as a variable that may inform monitoring or support decisions. This review provides a pragmatic framework for interpreting PaCO2 across respiratory support contexts and highlights the need for safe and clinically meaningful targets.

24 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CDCarmelo Dueñas-Castell
Carmelo Dueñas-Castell
Jose Alfredo Correa GuerreroJose Alfredo Correa Guerrero
Jose Alfredo Correa Guerrero
DBDayro Enrique Rodelo barrios
Dayro Enrique Rodelo barrios
LVLuis Valderrama-Ortiz
Luis Valderrama-Ortiz
CBCristhian Vallejo Burgos
Cristhian Vallejo Burgos
EOElber Luis Osorio-Rodriguez
Elber Luis Osorio-Rodriguez
Acute respiratory failure (ARF) often leads to ICU admission, ventilatory support, illness, and death. The usual classification into hypoxemic and hypercapnic types does not capture its full complexity. Precision medicine uses the idea of “treatable traits” to guide care based on traits that are clinically relevant, identifiable, measurable, and possibly changeable. Arterial carbon dioxide pressure (PaCO₂) reflects factors like alveolar ventilation, dead space, respiratory mechanics, and how patients respond to ventilatory support. This makes it a clinically relevant variable in selected situations in certain situations. We carried out a scoping review using PRISMA-ScR and JBI guidelines (OSF post hoc protocol https://osf.io/vszkg) to summarize evidence on hypocapnia and hypercapnia as prognostic, stratification, or clinically relevant variables during respiratory support. We searched PubMed/MEDLINE, ScienceDirect, and Web of Science (1994–2025), and checked references by hand. Thirty-four studies met our criteria and were grouped into four areas: pre-intubation or early acute presentation, non-invasive support (NIV/HFNC), invasive mechanical ventilation, and weaning or post-extubation. In summary, hypocapnia was linked to worse outcomes or failure of support in hypoxemic or cardiogenic cases. Hypercapnia helped identify patients who benefited from NIV, such as those with COPD or obesity-hypoventilation. For invasive mechanical ventilation, the effects depended on the presence and severity of acidosis and how long it lasted. We found that PaCO₂ is measurable and clinically important, but whether it can be targeted for treatment depends on the situation. More research is needed to set safe limits and practical targets.